There is currently no cure for AMD. Despite the advent of improved screening tools, which permit diagnosis to be made much earlier in the disease process, treatment options for AMD are limited.
Depending on the type of AMD, treatment options can aim to preserve vision for as long as possible, and in somecases may potentially provide vision improvement:
2RT™ Retinal Rejuvenation is a, minimally invasive intervention for intermediate AMD. It is the first and only treatment of its kind in the world. It is performed in your ophthalmologist’s clinic and typically takes no more than 10 minutes.
There are currently no treatments available to reverse the effects of dry AMD, although several are under development.
There are a number of drugs available to treat the blood vessels that grow abnormally into the retina and cause bleeding, leakage and scarring. Growth of these blood vessels is triggered by a protein called vascular endothelial growth factor (VEGF).
Anti-VEGF antibodies are injected into the eye, blocking the growth of the abnormal blood vessels. Injections should start as soon as possible after the new blood vessels form, and are required on a regular, ongoing basis, possibly for life, in order to preserve vision.